TABLE 4.
Relationship between the expression levels of miR‐204‐3p in peripheral blood and clinical features of DFU [( ± s), n (%)]
| DFU | |||
|---|---|---|---|
| High expression group (n = 43) | Low expression group (n = 39) | P value | |
| Age (year) | 52.3 ± 8.7 | 53.1 ± 9.5 | .236 |
| Sex | .681 | ||
| Male | 24 (55.8) | 20 (51.3) | |
| Female | 19 (44.2) | 19 (48.7) | |
| Ulcer area (cm2) | .967 | ||
| ≤5 | 8 (18.6) | 7 (17.9) | |
| 5‐10 | 22 (51.2) | 20 (51.3) | |
| >10 | 13 (30.2) | 12 (30.8) | |
| Ulcer duration (week) | .273 | ||
| ≤6 | 13 (30.2) | 6 (15.4) | |
| 6‐10 | 20 (46.5) | 23 (59.0) | |
| >10 | 10 (23.3) | 10 (25.6) | |
| Wagner grade | .985 | ||
| II | 10 (23.3) | 9 (23.1) | |
| III | 33 (66.7) | 30 (66.9) | |
| Outcome of ulcer after 8 weeks | .022 | ||
| Healing | 24 (55.8) | 12 (30.8) | |
| Non‐healing | 19 (44.2) | 27 (69.2) | |
Note: Data are presented mean ± standard deviations or numbers (%); Differences between two groups analysed using t test or χ2 test.
Abbreviations: DFU, diabetic foot ulcer; MiR, MicroRNA.